Posttransplant Lymphoproliferative Disorder Presenting as Multiple Cystic Lesions in a Renal Transplant Recipient

被引:3
作者
Moir, J. A. G. [1 ]
Simms, R. J. [2 ]
Wood, K. M. [3 ]
Talbot, D. [1 ]
Kanagasundaram, N. S. [2 ,4 ]
机构
[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Renal Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Upon Tyne Hosp NHS Fdn Trust, Renal Serv, Newcastle Upon Tyne, Tyne & Wear, England
[3] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Cellular Pathol, Newcastle Upon Tyne, Tyne & Wear, England
[4] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
基金
英国医学研究理事会;
关键词
Cystic lesions; PTLD; renal transplant; RISK-FACTOR; FDG-PET; RITUXIMAB; DISEASE; IMMUNOSUPPRESSION; ALLOGRAFT; THERAPY; LUNG; PTLD; LYMPHOCELE;
D O I
10.1111/j.1600-6143.2011.03761.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
We report a case of a 67-year-old man who experienced allograft dysfunction following a renal transplantation from a donation after cardiac death. The postoperative course was initially complicated by episodes of E. coli urinary sepsis causing pyrexia and a raised creatinine level. Ultrasound scanning 5 weeks posttransplant revealed mild hydronephrosis with several parenchymal cystic areas measuring up to 2 cm with appearances suggestive of fungal balls. Aspirated fluid again grew Escherichia coli, and this was treated with the appropriate antimicrobial therapy. The patient continued to have episodes of culture-negative sepsis; therefore, a computed tomography scan was performed 6 months posttransplant, which revealed multiple lesions in the renal cortex as well as liver and spleen. Subsequent biopsy revealed an EpsteinBarr virus-driven lymphoproliferation consistent with a polymorphic posttransplantation lymphoproliferative disorder (PTLD). This rare case of PTLD presenting as multiple renal, hepatic and splenic lesions emphasizes the need for a high index of clinical suspicion for this condition. Abnormal para-renal allograft masses should be biopsied to allow swift and effective management of a disease that can disseminate and become significantly more challenging to manage.
引用
收藏
页码:245 / 249
页数:5
相关论文
共 25 条
[1]  
ARMITAGE JM, 1991, J HEART LUNG TRANSPL, V10, P877
[2]   Early onset post-transplant lymphoproliferative disease is associated with allograft localization [J].
Bakker, NA ;
van Imhoff, GW ;
Verschuuren, EAM ;
van Son, WJ ;
van der Heide, JJH ;
Veeger, NJGM ;
Kluin, PM ;
Kluin-Nelemans, HC .
CLINICAL TRANSPLANTATION, 2005, 19 (03) :327-334
[3]   Posttransplant Lymphoproliferative Disorder in the Wall of a Lymphocele: A Case Report [J].
Basic-Jukic, N. ;
Kes, P. ;
Coric, M. ;
Kastelan, Z. ;
Pasini, J. ;
Bubic-Filipi, L. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (05) :1966-1968
[4]   Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients [J].
Beynet, DP ;
Wee, SA ;
Horwitz, SS ;
Kohler, S ;
Horning, S ;
Hoppe, R ;
Kim, YH .
ARCHIVES OF DERMATOLOGY, 2004, 140 (09) :1140-1146
[5]   Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se? [J].
Birkeland, SA ;
Hamilton-Dutoit, S .
TRANSPLANTATION, 2003, 76 (06) :984-988
[6]   Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression [J].
Caillard, S ;
Dharnidharka, V ;
Agodoa, L ;
Bohen, E ;
Abbott, K .
TRANSPLANTATION, 2005, 80 (09) :1233-1243
[7]   Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders:: results of a prospective multicenter phase 2 study [J].
Choquet, S ;
Leblond, V ;
Herbrecht, R ;
Socié, G ;
Stoppa, AM ;
Vandenberghe, P ;
Fischer, A ;
Morschhauser, F ;
Salles, G ;
Feremans, W ;
Vilmer, E ;
Peraldi, MN ;
Lang, P ;
Lebranchu, Y ;
Oksenhendler, E ;
Garnier, JL ;
Lamy, T ;
Jaccard, A ;
Ferrant, A ;
Offner, F ;
Hermine, O ;
Moreau, A ;
Fafi-Kremer, S ;
Morand, P ;
Chatenoud, L ;
Berriot-Varoqueaux, N ;
Bergougnoux, L ;
Milpied, N .
BLOOD, 2006, 107 (08) :3053-3057
[8]   RETICULUM CELL SARCOMA AFTER RENAL HOMOTRANSPLANTATION AND AZATHIOPRINE AND PREDNISONE THERAPY [J].
DOAK, PB ;
MONTGOME.JZ ;
NORTH, JDK ;
SMITH, F .
BRITISH MEDICAL JOURNAL, 1968, 4 (5633) :746-&
[9]   Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders [J].
Ghobrial, IM ;
Habermann, TM ;
Maurer, MJ ;
Geyer, SM ;
Ristow, KM ;
Larson, TS ;
Walker, RC ;
Ansell, SM ;
Macon, WR ;
Gores, GG ;
Stegall, MD ;
McGregor, CG .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7574-7582
[10]  
Kew CE, 2000, TRANSPLANTATION, V69, P809